Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Abad, S; Moachon, L; Blanche, P; Bavoux, F; Sicard, D; Salmon-Ceron, D
   Possible interaction between gliclazide, fluconazole and sulfamethoxazole resulting in severe hypoglycaemia
   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
   
   S. Abad et al., "Possible interaction between gliclazide, fluconazole and sulfamethoxazole resulting in severe hypoglycaemia", BR J CL PH, 52(4), 2001, pp. 456-457
2. Jonkers, FC; Guiot, Y; Rahier, J; Henquin, JC
   Tolbutamide stimulation of pancreatic beta-cells involves both cell recruitment and increase in the individual Ca2+ response
   BRITISH JOURNAL OF PHARMACOLOGY
   
   F.C. Jonkers et al., "Tolbutamide stimulation of pancreatic beta-cells involves both cell recruitment and increase in the individual Ca2+ response", BR J PHARM, 133(4), 2001, pp. 575-585
3. Reimann, F; Proks, P; Ashcroft, FM
   Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel
   BRITISH JOURNAL OF PHARMACOLOGY
   
   F. Reimann et al., "Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel", BR J PHARM, 132(7), 2001, pp. 1542-1548
4. Garber, AJ
   Using dose-response characteristics of therapeutic agents for treatment decisions in type 2 diabetes
   DIABETES OBESITY & METABOLISM
   
   A.J. Garber, "Using dose-response characteristics of therapeutic agents for treatment decisions in type 2 diabetes", DIABET OB M, 2(3), 2000, pp. 139-147
5. Howes, LG
   Cardiovascular effects of sulphonylureas: role of K-ATP channels
   DIABETES OBESITY & METABOLISM
   
   L.G. Howes, "Cardiovascular effects of sulphonylureas: role of K-ATP channels", DIABET OB M, 2(2), 2000, pp. 67-73
6. Charpentier, G; Riveline, JP; Varroud-Vial, M
   Management of drugs affecting blood glucose in diabetic patients with renal failure
   DIABETES & METABOLISM
   
   G. Charpentier et al., "Management of drugs affecting blood glucose in diabetic patients with renal failure", DIABETE MET, 26, 2000, pp. 73-85
7. Hanefeld, M; Goke, B
   Combining pioglitazone with a sulphonylurea or metformin in the managementof type 2 diabetes
   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
   
   M. Hanefeld e B. Goke, "Combining pioglitazone with a sulphonylurea or metformin in the managementof type 2 diabetes", EXP CL E D, 108, 2000, pp. S256-S266
8. Yudkin, JS; Panahloo, A; Stehouwer, C; Emeis, JJ; Bulmer, K; Mohamed-Ali, V; Denver, AE
   The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects
   DIABETOLOGIA
   
   J.S. Yudkin et al., "The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects", DIABETOLOG, 43(9), 2000, pp. 1099-1106
9. McKay, NG; Kinsella, JM; Campbell, CM; Ashford, MLJ
   Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodiumazide, to the K-ATP channel inhibitors, ciclazindol and englitazone
   BRITISH JOURNAL OF PHARMACOLOGY
   
   N.G. McKay et al., "Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodiumazide, to the K-ATP channel inhibitors, ciclazindol and englitazone", BR J PHARM, 130(4), 2000, pp. 857-866
10. Nattrass, M; Bailey, CJ
    New agents for Type 2 diabetes
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    
    M. Nattrass e C.J. Bailey, "New agents for Type 2 diabetes", BEST PRAC R, 13(2), 1999, pp. 309-329
11. Home, PD
    Rapid-acting insulin secretagogues: a clinical need?
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    P.D. Home, "Rapid-acting insulin secretagogues: a clinical need?", EXP CL E D, 107, 1999, pp. S115-S119
12. Willms, B; Ruge, D
    Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study
    DIABETIC MEDICINE
    
    B. Willms e D. Ruge, "Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study", DIABET MED, 16(9), 1999, pp. 755-761
13. Stahl, M; Berger, W
    Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas
    DIABETIC MEDICINE
    
    M. Stahl e W. Berger, "Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas", DIABET MED, 16(7), 1999, pp. 586-590
14. Gregorio, F; Ambrosi, F; Manfrini, S; Velussi, M; Carle, F; Testa, R; Merante, D; Filipponi, P
    Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin
    DIABETIC MEDICINE
    
    F. Gregorio et al., "Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin", DIABET MED, 16(12), 1999, pp. 1016-1024
15. Emilien, G; Maloteaux, JM; Ponchon, M
    Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment
    PHARMACOLOGY & THERAPEUTICS
    
    G. Emilien et al., "Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment", PHARM THERA, 81(1), 1999, pp. 37-51
16. Bokvist, K; Olsen, HL; Hoy, M; Gotfredsen, CF; Holmes, WF; Buschard, K; Rorsman, P; Gromada, J
    Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    
    K. Bokvist et al., "Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells", PFLUG ARCH, 438(4), 1999, pp. 428-436
17. Gribble, FM; Ashcroft, FM
    Differential sensitivity of beta-cell and extrapancreatic K-ATP channels to gliclazide
    DIABETOLOGIA
    
    F.M. Gribble e F.M. Ashcroft, "Differential sensitivity of beta-cell and extrapancreatic K-ATP channels to gliclazide", DIABETOLOG, 42(7), 1999, pp. 845-848
18. Sawada, K; Terada, T; Saito, H; Hashimoto, Y; Inui, K
    Effects of glibenclamide on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2
    BRITISH JOURNAL OF PHARMACOLOGY
    
    K. Sawada et al., "Effects of glibenclamide on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2", BR J PHARM, 128(6), 1999, pp. 1159-1164
19. Meyer, M; Chudziak, F; Schwanstecher, C; Schwanstecher, M; Panten, U
    Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes
    BRITISH JOURNAL OF PHARMACOLOGY
    
    M. Meyer et al., "Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes", BR J PHARM, 128(1), 1999, pp. 27-34
20. Anello, M; Gilon, P; Henquin, JC
    Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content
    BRITISH JOURNAL OF PHARMACOLOGY
    
    M. Anello et al., "Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content", BR J PHARM, 127(8), 1999, pp. 1883-1891
21. Chan, TYK
    Estimates on the incidence of antidiabetic drug-induced severe hypoglycaemia in Hong Kong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    
    T.Y.K. Chan, "Estimates on the incidence of antidiabetic drug-induced severe hypoglycaemia in Hong Kong", PHARMA D S, 7(6), 1998, pp. 411-414
22. Saito, N; Sakai, H; Suzuki, S; Sekihara, H; Yajima, Y
    Effect of an alpha-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    N. Saito et al., "Effect of an alpha-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients", J INT MED R, 26(5), 1998, pp. 219-232